| For: | Tang QL, Lai ML, Zhong YF, Wang AM, Su JK, Zhang MQ. Antinociceptive effect of berberine on visceral hypersensitivity in rats. World J Gastroenterol 2013; 19(28): 4582-4589 [PMID: 23901236 DOI: 10.3748/wjg.v19.i28.4582] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i28/4582.htm |
| Number | Citing Articles |
| 1 |
Toshikatsu Okumura, Tsukasa Nozu, Shima Kumei, Kaoru Takakusaki, Masumi Ohhira. Ghrelin acts centrally to induce an antinociceptive action during colonic distension through the orexinergic, dopaminergic and opioid systems in conscious rats. Brain Research 2018; 1686 doi: 10.1016/j.brainres.2018.02.024
|
| 2 |
Tsukasa Nozu, Saori Miyagishi, Shima Kumei, Rintaro Nozu, Kaoru Takakusaki, Toshikatsu Okumura. Glucagon‐like peptide‐1 analog, liraglutide, improves visceral sensation and gut permeability in rats. Journal of Gastroenterology and Hepatology 2018; 33(1) doi: 10.1111/jgh.13808
|
| 3 |
Hyun Jung Kim, Hyungwoo Kim, Myeong Ho Jung, Young Kyu Kwon, Byung Joo Kim. Berberine induces pacemaker potential inhibition via cGMP-dependent ATP-sensitive K+ channels by stimulating mu/delta opioid receptors in cultured interstitial cells of Cajal from mouse small intestine. Molecular Medicine Reports 2016; 14(4) doi: 10.3892/mmr.2016.5698
|
| 4 |
Toshikatsu Okumura, Tsukasa Nozu, Shima Kumei, Kaoru Takakusaki, Saori Miyagishi, Masumi Ohhira. Involvement of the dopaminergic system in the central orexin-induced antinociceptive action against colonic distension in conscious rats. Neuroscience Letters 2015; 605 doi: 10.1016/j.neulet.2015.08.013
|
| 5 |
Toshikatsu Okumura, Tsukasa Nozu, Shima Kumei, Kaoru Takakusaki, Saori Miyagishi, Masumi Ohhira. Levodopa acts centrally to induce an antinociceptive action against colonic distension through activation of D2 dopamine receptors and the orexinergic system in the brain in conscious rats. Journal of Pharmacological Sciences 2016; 130(2) doi: 10.1016/j.jphs.2016.01.007
|
| 6 |
Milad Rahemi, Shokooh Mohtadi, Hossein Rajabi Vardanjani, Mohammad Javad Khodayar. The role of l-arginine/NO/cGMP/KATP channel pathway in the local antinociceptive effect of berberine in the rat formalin test. Behavioural Pharmacology 2023; 34(8) doi: 10.1097/FBP.0000000000000721
|
| 7 |
Kuldeep Singh, Jeetendra Kumar Gupta, Divya Jain, Alka N Chaudhary, Shivendra Kumar, Mukesh Chandra Sharma, Bhupendra Singh. Unveiling the therapeutic potential of traditional Chinese medicine Rhizome Coptidis: A comprehensive review. Pharmacological Research - Modern Chinese Medicine 2024; 13 doi: 10.1016/j.prmcm.2024.100522
|
| 8 |
Toshikatsu Okumura, Tsukasa Nozu, Shima Kumei, Masumi Ohhira. Central oxytocin signaling mediates the central orexin-induced visceral antinociception through the opioid system in conscious rats. Physiology & Behavior 2019; 198 doi: 10.1016/j.physbeh.2018.10.007
|
| 9 |
Luis Guamán Ortiz, Paolo Lombardi, Micol Tillhon, Anna Scovassi. Berberine, an Epiphany Against Cancer. Molecules 2014; 19(8) doi: 10.3390/molecules190812349
|
| 10 |
Anthony C. Johnson, Beverley Greenwood-Van Meerveld. Gastrointestinal Pharmacology. Handbook of Experimental Pharmacology 2017; 239 doi: 10.1007/164_2016_120
|
| 11 |
Fan-Cheng Meng, Zheng-Feng Wu, Zhi-Qi Yin, Li-Gen Lin, Ruibing Wang, Qing-Wen Zhang. Coptidis rhizoma and its main bioactive components: recent advances in chemical investigation, quality evaluation and pharmacological activity. Chinese Medicine 2018; 13(1) doi: 10.1186/s13020-018-0171-3
|
| 12 |
Jessie Pettit, Richard Glickman-Simon. Osteopathic Manipulative Therapy for Preterm Infants, Acupuncture for Menopausal Symptoms, Mindfulness-Based Stress Reduction for Chronic Low Back Pain, Chocolate for Ischemic Heart Disease, Berberine for Irritable Bowel Syndrome. EXPLORE 2016; 12(5) doi: 10.1016/j.explore.2016.06.015
|
| 13 |
Songgang Gu, Xuhong Song, Rufei Xie, Cong Ouyang, Lingzhu Xie, Qidong Li, Ting Su, Man Xu, Tian Xu, Dongyang Huang, Bin Liang. Berberine inhibits cancer cells growth by suppressing fatty acid synthesis and biogenesis of extracellular vesicles. Life Sciences 2020; 257 doi: 10.1016/j.lfs.2020.118122
|
| 14 |
Nian-zhao Zhang, Lin Ma, Chen Jun, Yan-xia Guo, Hui-qing Yuan. Changes in mast cell infiltration: a possible mechanism in detrusor overactivity induced by visceral hypersensitivity. International braz j urol 2016; 42(2) doi: 10.1590/S1677-5538.IBJU.2015.0025
|
| 15 |
Beverley Greenwood-Van Meerveld, Dawn K. Prusator, Anthony C. Johnson. Animal models of gastrointestinal and liver diseases. Animal models of visceral pain: pathophysiology, translational relevance, and challenges. American Journal of Physiology-Gastrointestinal and Liver Physiology 2015; 308(11) doi: 10.1152/ajpgi.00463.2014
|
| 16 |
Tsukasa Nozu, Saori Miyagishi, Rintaro Nozu, Kaoru Takakusaki, Toshikatsu Okumura. Dehydroepiandrosterone sulfate improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome. European Journal of Pharmacology 2019; 852 doi: 10.1016/j.ejphar.2019.03.037
|
| 17 |
Tsukasa Nozu, Saori Miyagishi, Rintaro Nozu, Kaoru Takakusaki, Toshikatsu Okumura. Repeated water avoidance stress induces visceral hypersensitivity: Role of interleukin‐1, interleukin‐6, and peripheral corticotropin‐releasing factor. Journal of Gastroenterology and Hepatology 2017; 32(12) doi: 10.1111/jgh.13787
|
| 18 |
Tsukasa Nozu, Saori Miyagishi, Rintaro Nozu, Kaoru Takakusaki, Toshikatsu Okumura. Losartan improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome. Neurogastroenterology & Motility 2020; 32(6) doi: 10.1111/nmo.13819
|
| 19 |
Ashis Kumar Goswami, Neelutpal Gogoi, Anshul Shakya, Hemanta Kumar Sharma. Development and Validation of High-Performance Thin-layer Chromatographic Method for Quantification of Berberine in Rhizomes of Coptis teeta Wall, an Endangered Species Collected from Arunachal Pradesh, India. Journal of Chromatographic Science 2019; 57(5) doi: 10.1093/chromsci/bmz009
|
| 20 |
Chunqiu Chen, Zhen Yu, Yongyu Li, Jakub Fichna, Martin Storr. Effects of Berberine in the Gastrointestinal Tract — A Review of Actions and Therapeutic Implications. The American Journal of Chinese Medicine 2014; 42(05) doi: 10.1142/S0192415X14500669
|
| 21 |
Kosar Namakin, Meysam Hassani Moghaddam, Sara Sadeghzadeh, Maryam Mehranpour, Kimia Vakili, Mobina Fathi, Ahmadreza Golshan, Amir-Hossein Bayat, Amir-Hossein Tajik, Neda Eskandari, Ibrahim Mohammadzadeh, Soheila Zamanlui Benisi, Abbas Aliaghaei, Mohammad-Amin Abdollahifar. Elderberry diet improves gut-brain axis dysfunction, neuroinflammation, and cognitive impairment in the rat model of irritable bowel syndrome. Metabolic Brain Disease 2023; 38(5) doi: 10.1007/s11011-023-01187-6
|
| 22 |
İbrahim BAŞHAN. Effect of berberine on irritable bowel syndrome: A symptom-based review. International Journal of Plant Based Pharmaceuticals 2022; doi: 10.55484/ijpbp.1084455
|
| 23 |
Ursula Wade, Domingo A. Pascual-Figal, Fazale Rabbani, Marie Ernst, Adelin Albert, Isabelle Janssens, Yvan Dierckxsens, Somia Iqtadar, Nisar A. Khokhar, Ayesha Kanwal, Amjad Khan. The Possible Synergistic Pharmacological Effect of an Oral Berberine (BBR) and Curcumin (CUR) Complementary Therapy Alleviates Symptoms of Irritable Bowel Syndrome (IBS): Results from a Real-Life, Routine Clinical Practice Settings-Based Study. Nutrients 2024; 16(8) doi: 10.3390/nu16081204
|
| 24 |
Rafa S. Almeer, Ahmed M. Aref, Romisa A. Hussein, Mohamed S. Othman, Ahmed E. Abdel Moneim. Antitumor Potential of Berberine and Cinnamic Acid against Solid Ehrlich Carcinoma in Mice. Anti-Cancer Agents in Medicinal Chemistry 2019; 19(3) doi: 10.2174/1871520618666181116162441
|
| 25 |
Mahmoud Hashemzaei, Ramin Rezaee. A review on pain‐relieving activity of berberine. Phytotherapy Research 2021; 35(6) doi: 10.1002/ptr.6984
|
| 26 |
Mehran Shayganfard. Berberine: Is it a Promising Agent for Mental Disorders Treatment?. Current Molecular Pharmacology 2023; 16(3) doi: 10.2174/1874467215666220509213122
|
| 27 |
Lin Yang, Hua Luo, Dechao Tan, Siyuan Zhang, Zhangfeng Zhong, Shengpeng Wang, Chi Teng Vong, Yitao Wang. A recent update on the use of Chinese medicine in the treatment of inflammatory bowel disease. Phytomedicine 2021; 92 doi: 10.1016/j.phymed.2021.153709
|
| 28 |
. 2015; doi: 10.70675/4921df7dzfe9cz4ac8z8b00zebcf9d144dc0
|
| 29 |
Toshikatsu Okumura, Tsukasa Nozu, Shima Kumei, Kaoru Takakusaki, Saori Miyagishi, Masumi Ohhira. Antinociceptive action against colonic distension by brain orexin in conscious rats. Brain Research 2015; 1598 doi: 10.1016/j.brainres.2014.12.021
|
| 30 |
Tsukasa Nozu, Saori Miyagishi, Rintaro Nozu, Kaoru Takakusaki, Toshikatsu Okumura. Lipopolysaccharide induces visceral hypersensitivity: role of interleukin-1, interleukin-6, and peripheral corticotropin-releasing factor in rats. Journal of Gastroenterology 2017; 52(1) doi: 10.1007/s00535-016-1208-y
|
| 31 |
Pengfei Zhang, Wencong Huang, Daijie Wang, Jiaxin Liu, Yutin Zhang, Chengyan Jing, Yonglan Pan, Yonghai Liu, Xingde Zhang. Tautomeric asymmetric self–inhibition: an underexploited pH–dependent strategy to enhance berberrubine solubility. International Journal of Pharmaceutics 2026; 704 doi: 10.1016/j.ijpharm.2026.127445
|
| 32 |
Mohammad H Farzaei, Roodabeh Bahramsoltani, Mohammad Abdollahi, Roja Rahimi. The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments. Journal of Neurogastroenterology and Motility 2016; 22(4) doi: 10.5056/jnm16001
|
| 33 |
Yan-Xiang Wang, Lu Liu, Qing-Xuan Zeng, Tian-Yun Fan, Jian-Dong Jiang, Hong-Bin Deng, Dan-Qing Song. Synthesis and Identification of Novel Berberine Derivatives as Potent Inhibitors against TNF-α-Induced NF-κB Activation. Molecules 2017; 22(8) doi: 10.3390/molecules22081257
|
| 34 |
Chunqiu Chen, Meiling Lu, Qiuhui Pan, Jakub Fichna, Lijun Zheng, Kesheng Wang, Zhen Yu, Yongyu Li, Kun Li, Aihong Song, Zhongchen Liu, Zhenshun Song, Martin Kreis, Yvette Tache. Berberine Improves Intestinal Motility and Visceral Pain in the Mouse Models Mimicking Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Symptoms in an Opioid-Receptor Dependent Manner. PLOS ONE 2015; 10(12) doi: 10.1371/journal.pone.0145556
|
| 35 |
Tsukasa Nozu, Saori Miyagishi, Masatomo Ishioh, Kaoru Takakusaki, Toshikatsu Okumura. Peripheral apelin mediates visceral hypersensitivity and impaired gut barrier in a rat irritable bowel syndrome model. Neuropeptides 2022; 94 doi: 10.1016/j.npep.2022.102248
|
| 36 |
Chunsheng Wang, Rong Chang, Gan Gao, Xing Liu, Yingwei Zhang. RETRACTED ARTICLE: Fibrauretine reduces ischemia/reperfusion injury via RISK/eNOS activation. Naunyn-Schmiedeberg's Archives of Pharmacology 2020; 393(8) doi: 10.1007/s00210-019-01770-8
|
| 37 |
Chunqiu Chen, Chunhua Tao, Zhongchen Liu, Meiling Lu, Qiuhui Pan, Lijun Zheng, Qing Li, Zhenshun Song, Jakub Fichna. A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea‐Predominant Irritable Bowel Syndrome. Phytotherapy Research 2015; 29(11) doi: 10.1002/ptr.5475
|
| 38 |
P.M. Oliveira, T.Z. Lopes, A.C. Tedesco, P. Rahal, M.F. Calmon. Effect of berberine associated with photodynamic therapy in cell lines. Photodiagnosis and Photodynamic Therapy 2020; 32 doi: 10.1016/j.pdpdt.2020.102045
|
| 39 |
Yun-Yun Shao, Yi-Ting Guo, Jian-ping Gao, Jun-Jin Liu, Zhuang-Peng Chang, Xiao-Juan Feng, Ding Xu, Gui-Feng Deng, Rui-Gang Hou, XiuMin Li. Shaoyao‐Gancao Decoction Relieves Visceral Hyperalgesia in TNBS‐Induced Postinflammatory Irritable Bowel Syndrome via Inactivating Transient Receptor Potential Vanilloid Type 1 and Reducing Serotonin Synthesis. Evidence-Based Complementary and Alternative Medicine 2020; 2020(1) doi: 10.1155/2020/7830280
|
| 40 |
Zhi-Chao Yu, Yong-Xin Cen, Ben-Hua Wu, Cheng Wei, Feng Xiong, De-Feng Li, Ting-Ting Liu, Ming-Han Luo, Li-Liangzi Guo, Ying-Xue Li, Li-Sheng Wang, Jian-Yao Wang, Jun Yao. Berberine prevents stress-induced gut inflammation and visceral hypersensitivity and reduces intestinal motility in rats. World Journal of Gastroenterology 2019; 25(29): 3956-3971 doi: 10.3748/wjg.v25.i29.3956
|
| 41 |
Tsukasa Nozu, Saori Miyagishi, Masatomo Ishioh, Kaoru Takakusaki, Toshikatsu Okumura. Repurposing Cimetidine as a Therapeutic Candidate for Irritable Bowel Syndrome in a Rat Model. Fundamental & Clinical Pharmacology 2026; 40(3) doi: 10.1111/fcp.70091
|
| 42 |
T. Nozu, S. Miyagishi, R. Nozu, K. Takakusaki, T. Okumura. Water avoidance stress induces visceral hyposensitivity through peripheral corticotropin releasing factor receptor type 2 and central dopamine D2 receptor in rats. Neurogastroenterology & Motility 2016; 28(4) doi: 10.1111/nmo.12747
|
| 43 |
Shima Kumei, Masatomo Ishioh, Tsukasa Nozu, Toshikatsu Okumura. Prostaglandin I2 suppresses the development of gut-brain axis disorder in irritable bowel syndrome in rats. Biochimica et Biophysica Acta (BBA) - General Subjects 2023; 1867(5) doi: 10.1016/j.bbagen.2023.130344
|
| 44 |
Pengfei Zhang, Hailong Li, Peipei Han, Haoting Yu, Wanting Wang, Xingde Zhang, Yonghai Liu. Cocrystal of berberine with its metabolite: a new strategy to improve the physicochemical properties of berberine. Journal of Drug Delivery Science and Technology 2025; 110 doi: 10.1016/j.jddst.2025.107027
|
| 45 |
Toshikatsu Okumura, Tsukasa Nozu, Shima Kumei, Kaoru Takakusaki, Saori Miyagishi, Masumi Ohhira. Adenosine A1 receptors mediate the intracisternal injection of orexin-induced antinociceptive action against colonic distension in conscious rats. Journal of the Neurological Sciences 2016; 362 doi: 10.1016/j.jns.2016.01.031
|
| 46 |
Patricia J. Yang, Morgan LaMarca, Candice Kaminski, Daniel I. Chu, David L. Hu. Hydrodynamics of defecation. Soft Matter 2017; 13(29) doi: 10.1039/C6SM02795D
|
| 47 |
Yuhan Yang, Chi Teng Vong, Shan Zeng, Caifang Gao, Zhejie Chen, Chaomei Fu, Shengpeng Wang, Liang Zou, Anqi Wang, Yitao Wang. Tracking evidences of Coptis chinensis for the treatment of inflammatory bowel disease from pharmacological, pharmacokinetic to clinical studies. Journal of Ethnopharmacology 2021; 268 doi: 10.1016/j.jep.2020.113573
|
| 48 |
Yulin Lu, Jingjing Huang, Yao Zhang, Zitong Huang, Weiming Yan, Tianran Zhou, Zhesheng Wang, Lu Liao, Hongying Cao, Bo Tan. Therapeutic Effects of Berberine Hydrochloride on Stress-Induced Diarrhea-Predominant Irritable Bowel Syndrome Rats by Inhibiting Neurotransmission in Colonic Smooth Muscle. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.596686
|
| 49 |
Solomon Habtemariam. Berberine and inflammatory bowel disease: A concise review. Pharmacological Research 2016; 113 doi: 10.1016/j.phrs.2016.09.041
|
| 50 |
Anurag K. Singh, Santosh K. Singh, Manmath K. Nandi, Gaurav Mishra, Anand Maurya, Arati Rai, Gopal K. Rai, Rajendra Awasthi, Bhupesh Sharma, Giriraj T. Kulkarni. Berberine: A Plant-derived Alkaloid with Therapeutic Potential to Combat Alzheimer’s disease. Central Nervous System Agents in Medicinal Chemistry 2019; 19(3) doi: 10.2174/1871524919666190820160053
|
| 51 |
Xinghua Gao, Jikai Liu, Daming Fan, Xiaofeng Li, Zhiqing Fang, Keqiang Yan, Yidong Fan. Berberine enhances gemcitabine‑induced cytotoxicity in bladder cancer by downregulating Rad51 expression through inactivating the PI3K/Akt pathway. Oncology Reports 2021; 47(2) doi: 10.3892/or.2021.8244
|
| 52 |
Sahil J. Somani, Ketan P. Modi, Anuradha S. Majumdar, Bhakti N. Sadarani. Phytochemicals and Their Potential Usefulness in Inflammatory Bowel Disease. Phytotherapy Research 2015; 29(3) doi: 10.1002/ptr.5271
|
| 53 |
Przemysław Łukasz Mikołajczak, Bogdan Kędzia, Marcin Ożarowski, Radosław Kujawski, Anna Bogacz, Joanna Bartkowiak-Wieczorek, Wojciech Białas, Agnieszka Gryszczyńska, Waldemar Buchwald, Michał Szulc, Natalia Wasiak, Małgorzata Górska-Paukszta, Justyna Baraniak, Bogusław Czerny, Agnieszka Seremak-Mrozikiewicz. Evaluation of anti-inflammatory and analgesic activities of extracts from herb of <i>Chelidonium majus L.</i>. Central European Journal of Immunology 2016; 40(4) doi: 10.5114/ceji.2015.54607
|